Company Name: |
Bide Pharmatech Ltd.
|
Tel: |
400-164-7117 13681763483 |
Email: |
product02@bidepharm.com |
Products Intro: |
Product Name:(R)-2-([1,1'-Biphenyl]-4-sulfonamido)-N-hydroxy-3-phenylpropanamide CAS:193807-60-2 Purity:97% Package:10mg;25mg;50mg;100mg Remarks:BD01136274
|
- BPHA
-
- $179.00 / 1mg
-
2025-05-09
- CAS:193807-60-2
- Min. Order:
- Purity: 99.72%
- Supply Ability: 10g
|
| MMP-9 Inhibitor II Basic information |
Product Name: | MMP-9 Inhibitor II | Synonyms: | Matrix Metalloproteinase-2/Matrix Metalloproteinase-9 Inhibitor II;MMP-2/MMP-9 INHIBITOR II;MATRIX METALLOPROTEINASE-2/MATRIX METALLOPROTEINASE-9 INHIBITOR II;Benzenepropanamide, α-[([1,1'-biphenyl]-4-ylsulfonyl)amino]-N-hydroxy-, (αR)-;BPHA, 10 mM in DMSO;(R)-2-([1,1'-Biphenyl]-4-sulfonamido)-N-hydroxy-3-phenylpropanamide | CAS: | 193807-60-2 | MF: | C21H20N2O4S | MW: | 396.46 | EINECS: | | Product Categories: | | Mol File: | 193807-60-2.mol |  |
| MMP-9 Inhibitor II Chemical Properties |
Melting point | 169-170 °C | density | 1.309±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO: 100 mg/ml; Methanol: 25 mg/ml | form | A solid | pka | 9.03±0.40(Predicted) | color | off-white |
| MMP-9 Inhibitor II Usage And Synthesis |
Uses | MMP-2/MMP-9 Inhibitor II is a potent inhibitor of MMP-2 and MMP-9. | Biological Activity | Cell permeable: no', 'Primary Target MMP-2', 'Product does not compete with ATP.', 'Reversible: no', 'Target IC50: 17 nM, 30 nM against MMP-2, and MMP-9, respectively | in vivo | Daily oral administration of 200 mg/kg BPHA in mice results in potent inhibition of tumor-induced angiogenesis, primary tumor growth, and liver metastasis. The growth inhibition activity of BPHA is 48% and 45% in a B16-BL6 melanoma and F2 hemangio-endothelioma model, respectively[1]. | IC 50 | MMP-2: 12 nM (IC50); MMP-9: 16 nM (IC50); MMP-14: 17 nM (IC50); MMP-1: 974 nM (IC50); MMP-3: >1000 nM (IC50); MMP-7: 795 nM (IC50) |
| MMP-9 Inhibitor II Preparation Products And Raw materials |
|